Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus

Respiratory syncytial virus (RSV) causes disease early in life and can reinfect symptomatically throughout life without undergoing significant antigenic change. In contrast, reinfection by influenza A virus (IAV) requires antigenic change. The adaptive immune response depends on antigen presentation by dendritic cells (DC). We used myeloid DC (mDC) from cord blood and adult blood donors to evaluate whether immunological immaturity contributes to the inability to mount a fully protective immune response to RSV. While IAV induced some activation and chemokine receptor switching in cord blood mDC, RSV did not. This appeared to be due to a lack of activation and a weak and mostly reversible inhibition of DC functions. Both viruses induced a stronger activation of mDC from adults than mDC from cord blood. Thus, inefficient stimulation of mDC by RSV and immunological immaturity may contribute to reduced immune responses and increased susceptibility to RSV disease and reinfection in young infants. ABSTRACT Respiratory syncytial virus (RSV) infects and causes disease in infants and reinfects with reduced disease throughout life without significant antigenic change. In contrast, reinfection by influenza A virus (IAV) largely requires antigenic change. The adaptive immune response depends on antigen presentation by dendritic cells (DC), which may be too immature in young infants to induce a fully protective immune response against RSV reinfections. We therefore compared the ability of RSV and IAV to activate primary human cord blood (CB) and adult blood (AB) myeloid DC (mDC). While RSV and IAV infected with similar efficiencies, RSV poorly induced maturation and cytokine production in CB and AB mDC. This difference between RSV and IAV was more profound in CB mDC. While IAV activated CB mDC to some extent, RSV did not induce CB mDC to increase the maturation markers CD38 and CD86 or CCR7, which directs DC migration to lymphatic tissue. Low CCR7 surface expression was associated with high expression of CCR5, which keeps DC in inflamed peripheral tissues. To evaluate a possible inhibition by RSV, we subjected RSV-inoculated AB mDC to secondary IAV inoculation. While RSV-inoculated AB mDC responded to secondary IAV inoculation by efficiently upregulating activation markers and cytokine production, IAV-induced CCR5 downregulation was slightly inhibited in cells exhibiting robust RSV infection. Thus, suboptimal stimulation and weak and mostly reversible inhibition seem to be responsible for inefficient mDC activation by RSV. The inefficient mDC stimulation and immunological immaturity in young infants may contribute to reduced immune responses and incomplete protection against RSV reinfection. IMPORTANCE Respiratory syncytial virus (RSV) causes disease early in life and can reinfect symptomatically throughout life without undergoing significant antigenic change. In contrast, reinfection by influenza A virus (IAV) requires antigenic change. The adaptive immune response depends on antigen presentation by dendritic cells (DC). We used myeloid DC (mDC) from cord blood and adult blood donors to evaluate whether immunological immaturity contributes to the inability to mount a fully protective immune response to RSV. While IAV induced some activation and chemokine receptor switching in cord blood mDC, RSV did not. This appeared to be due to a lack of activation and a weak and mostly reversible inhibition of DC functions. Both viruses induced a stronger activation of mDC from adults than mDC from cord blood. Thus, inefficient stimulation of mDC by RSV and immunological immaturity may contribute to reduced immune responses and increased susceptibility to RSV disease and reinfection in young infants.

[1]  B. Kampmann,et al.  Vaccine responses in newborns , 2017, Seminars in Immunopathology.

[2]  M. Heim,et al.  SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo , 2017, The Journal of Biological Chemistry.

[3]  J. Schwarze,et al.  Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis , 2016, Thorax.

[4]  R. Garofalo,et al.  Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection , 2013, Respiratory Research.

[5]  R. Rabin,et al.  Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent , 2012, Immunology and cell biology.

[6]  R. Rabin,et al.  Low CCR7-Mediated Migration of Human Monocyte Derived Dendritic Cells in Response to Human Respiratory Syncytial Virus and Human Metapneumovirus , 2011, PLoS pathogens.

[7]  B. Graham,et al.  Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus , 2011, PloS one.

[8]  R. Rabin,et al.  Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+ T Cell Activation by Dendritic Cells , 2010, PloS one.

[9]  J. Crowe,et al.  Transforming Growth Factor Beta Is a Major Regulator of Human Neonatal Immune Responses following Respiratory Syncytial Virus Infection , 2010, Journal of Virology.

[10]  K. Poehling,et al.  The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.

[11]  S. Self,et al.  Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults1 , 2009, The Journal of Immunology.

[12]  R. Rabin,et al.  Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. , 2009, Virology.

[13]  M. Suter,et al.  Phenotype and function of neonatal DC , 2009, European journal of immunology.

[14]  U. V. von Andrian,et al.  Mechanisms and consequences of dendritic cell migration. , 2008, Immunity.

[15]  P. Collins,et al.  Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells , 2008, Journal of Virology.

[16]  Antal Rot,et al.  CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.

[17]  B. Graham,et al.  Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis , 2007, Journal of Virology.

[18]  C. Chougnet,et al.  Defective antigen-presenting cell function in human neonates. , 2006, Clinical immunology.

[19]  C. Sousa,et al.  Dendritic cells in a mature age , 2006, Nature Reviews Immunology.

[20]  S. Deaglio,et al.  CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. , 2006, Blood.

[21]  J. Banchereau,et al.  Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. , 2005, The Journal of infectious diseases.

[22]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[23]  B. Murphy,et al.  Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. , 2004, Virology.

[24]  T. Rothoeft,et al.  Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon‐γ in naïve T cells , 2003 .

[25]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[26]  U. Schauer,et al.  Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells , 2002, Clinical and experimental immunology.

[27]  R. Chanock,et al.  Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. , 1988, Virus research.

[28]  R. Karron,et al.  Respiratory syncytial virus and metapneumovirus , 2007 .

[29]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.